All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

Should COVID-19 vaccination be postponed after AML therapy?

Mar 8, 2022

During the 63rd ASH Annual Meeting and Exposition, the AML hub spoke with Sabine Haggenburg, Amsterdam UMC, Amsterdam, NL. We asked, Should COVID-19 vaccination be postponed after AML therapy?

Should COVID-19 vaccination be postponed after AML therapy?

Haggenburg begins by discussing COVID-19 risks to AML patients, and the responses to vaccinations that have been observed so far. However, she highlights that vaccination does not protect patients taking hypomethylating agents (HMAs), such as azacitidine and decitabine.



Subscribe to get the best content related to AML delivered to your inbox